AI and NLP For Quantitative Social Media Listening In Pharmaceutical Drug Development
Wednesday, 15th May, 2024
10am ET | 3pm BST | 7am PT
Social media listening (SML) has the potential to help many facets of drug development in the quest for patient-centric therapies that are fit for purpose.
- What NLP is and how it can be used to get deeper value from social media
- AI and NLP use for insights and trends from SML
- How to use social media for patient voice to inform clinical trial design and decision making
- The benefits and potential of Quantitative Social Media Listening (QSML)
Meet the Speakers

Raul Rodriguez-Esteban
Senior Principal Scientist at Roche Pharmaceutical

Jane Reed
Director of NLP at Linguamatics IQVIA